alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › prevention

prevention

3 studies tagged prevention, dated 2022-01-01 to 2024-01-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Health Economic Considerations in the Deployment of an Alzheimer's Prevention Therapy 2024-01-01
  2. Blood Derived Amyloid Biomarkers for Alzheimer's Disease Prevention 2022-01-01
  3. Study Protocol of a Comprehensive Activity Promotion Program for the Prevention of Dementia: A Randomized Controlled Trial Protocol 2022-01-01

Studies

3 studies carry this tag.

Date range

2022 to 2024

Top journals

  • The journal of prevention of Alzheimer's disease 3

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Health Economic Considerations in the Deployment of an Alzheimer's Prevention Therapy

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. The journal of prevention of Alzheimer's disease 2024-01-01 Biomarkers

    The program would generate per-person value of $53,721 from a payer (reduction of direct cost and patient QALY gains) and $69,861 from a societal perspective (adding valuation of reduced caregiver burden).

  2. Blood Derived Amyloid Biomarkers for Alzheimer's Disease Prevention

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. The journal of prevention of Alzheimer's disease 2022-01-01 Biomarkers

    We also explored economic viability of using two different plasma amyloid assays for pre-screening in AD prevention trials and as routine clinical diagnostic tool, versus amyloid PET alone.

  3. Study Protocol of a Comprehensive Activity Promotion Program for the Prevention of Dementia: A Randomized Controlled Trial Protocol

    ✓ Peer-reviewed alzhub usefulness score 81 out of 100. The journal of prevention of Alzheimer's disease 2022-01-01 Cognitive tests and assessment

    This study has the potential to provide the first evidence of the effectiveness of information communication technology and Internet of Things in incident dementia.

All topic tags with their study counts